Project Name: West of Scotland (Wishaw Cluster) - Heart Failure Audit and Medicines Optimisation Collaborative Working
Project Summary:
The Collaborative Working Project (CWP) with 6 general medical practices (Wishaw Cluster Practices) within NHS Lanarkshire has three main aims:
- To identify known patients with heart failure with reduced ejection fraction (HFrEF) in each general practice and optimise their current heart failure (HF) medications in line with local HF guidelines within the primary care setting.
- To identify suspected, but currently undiagnosed, HF patients and refer such patients via the NHS Lanarkshire Heart Failure Diagnostic Pathway for formal diagnosis via echocardiogram.
- To better manage known HFrEF patients within these general practices on a long-term basis. In addition, it will support with new HF patient identification.
Planned Milestones:
Expected Benefits:
Benefits to Patients
- Improved access to diagnosis and treatment
- More equitable and consistent care and access to care
- “Care Closer to Home” potential
- Enhanced experience for patients and their carers who live with HF Opportunity to prevent traumatic HF decompensations and hospitalisations
Benefits to NHS Organisations
- General practices can complete data cleansing and validation of HF
- Increase the overall quality of care and improve equity of access to primary and specialist care for patients with HF
- Improve knowledge and competence of existing NHS staff to better understand and manage HF
- Development of HF Toolkit, which may inform ongoing redesign and workforce planning at a national level through Heart Failure Hub Scotland
Benefits to Novartis
- Further opportunities for the appropriate use of HF licensed medicines in line with local guidelines, including Novartis’ medicines
- Ethical, professional, and transparent relationship between Novartis and the Healthcare Organisations
Start Date & Duration:
Initiation: December 2022
Duration: 12 months
UK | December 2022 | 576448